HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Aug 20, 2025 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a routine 6-K, confirming its status as a foreign private issuer.
AI Summary
HUTCHMED (China) Ltd filed a Form 6-K on August 20, 2025, reporting as a foreign private issuer. The company, formerly known as Hutchison China MediTech Ltd, is based in Hong Kong and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates ongoing reporting requirements for HUTCHMED (China) Ltd as a foreign private issuer, providing transparency to investors about its regulatory status.
Risk Assessment
Risk Level: low — This filing is a standard regulatory report and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- HUTCHMED (China) Ltd (company) — Filer of the 6-K report
- Hutchison China MediTech Ltd (company) — Former name of the registrant
- August 20, 2025 (date) — Date of the filing
- Hong Kong (location) — Company's principal executive office location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes public in its home country, files with a stock exchange, or distributes to its security holders.
When was HUTCHMED (China) Ltd formerly known as?
HUTCHMED (China) Ltd was formerly known as Hutchison China MediTech Ltd.
What is the SEC file number for HUTCHMED (China) Ltd?
The SEC file number for HUTCHMED (China) Ltd is 001-37710.
Where are HUTCHMED (China) Ltd's principal executive offices located?
HUTCHMED (China) Ltd's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Ltd file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Ltd files annual reports under Form 20-F, as indicated by the check mark next to it.
Filing Stats: 181 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-08-20 06:12:04
Filing Documents
- hcm-20250820x6k.htm (6-K) — 22KB
- hcm-20250820xex99d1.htm (EX-99.1) — 42KB
- hcm-20250820xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-25-000055.txt ( ) — 71KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED completes patient enrollment of SANOVO phase III trial of ORPATHYS and TAGRISSO combination as a first-line therapy for certain lung cancer patients in China 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: August 20, 2025 3